Large cell carcinoma of the lung surgery: Difference between revisions

Jump to navigation Jump to search
 
Line 8: Line 8:


==Surgery==
==Surgery==
*Surgery is the mainstay of treatment for large cell carcinoma of the lung.<ref name="pmid15063228">{{cite journal |vauthors=Doddoli C, Barlesi F, Chetaille B, Garbe L, Thomas P, Giudicelli R, Fuentes P |title=Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery |journal=Ann. Thorac. Surg. |volume=77 |issue=4 |pages=1168–72 |date=April 2004 |pmid=15063228 |doi=10.1016/j.athoracsur.2003.09.049 |url=}}</ref><ref name="pmid16618956">{{cite journal |vauthors=Smetana GW, Lawrence VA, Cornell JE |title=Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians |journal=Ann. Intern. Med. |volume=144 |issue=8 |pages=581–95 |year=2006 |pmid=16618956 |doi= |url=}}</ref>
*Surgery is the mainstay of treatment for large cell carcinoma of the lung.<ref name="pmid15063228">{{cite journal |vauthors=Doddoli C, Barlesi F, Chetaille B, Garbe L, Thomas P, Giudicelli R, Fuentes P |title=Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery |journal=Ann. Thorac. Surg. |volume=77 |issue=4 |pages=1168–72 |date=April 2004 |pmid=15063228 |doi=10.1016/j.athoracsur.2003.09.049 |url=}}</ref><ref name="pmid16618956">{{cite journal |vauthors=Smetana GW, Lawrence VA, Cornell JE |title=Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians |journal=Ann. Intern. Med. |volume=144 |issue=8 |pages=581–95 |year=2006 |pmid=16618956 |doi= |url=}}</ref><ref name="pmid9458138">{{cite journal |vauthors=Wertzel H, Grahmann PR, Bansbach S, Lange W, Hasse J, Böhm N |title=Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression |journal=Eur J Cardiothorac Surg |volume=12 |issue=5 |pages=698–702 |date=November 1997 |pmid=9458138 |doi= |url=}}</ref>
*The feasibility of surgery depends on the stage of squamous cell carcinoma of the lung at diagnosis.
*The feasibility of surgery depends on the stage of squamous cell carcinoma of the lung at diagnosis.
*Surgical intervention is not recommended for the management of metastatic squamous cell carcinoma of the lung.
*Surgical intervention is not recommended for the management of metastatic squamous cell carcinoma of the lung.

Latest revision as of 21:03, 3 March 2018

Large Cell Carcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Large Cell Carcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Large cell carcinoma of the lung surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Large cell carcinoma of the lung surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Large cell carcinoma of the lung surgery

CDC on Large cell carcinoma of the lung surgery

Large cell carcinoma of the lung surgery in the news

Blogs on Large cell carcinoma of the lung surgery

Directions to Hospitals Treating Large cell carcinoma of the lung

Risk calculators and risk factors for Large cell carcinoma of the lung surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Surgery is the mainstay of treatment for large cell carcinoma of the lung. Common surgical procedures for the treatment of large cell carcinoma of the lung, include: pulmonary lobectomy, pneumonectomy, lung resection with lobectomy, lung resection with pneumonectomy with or without lymph node dissection. The preferred surgical procedure is thoracotomy with removal of the entire lung or lobe (lobectomy) along with regional lymph nodes and contiguous structures. Common complications of squamous cell carcinoma of the lung surgery, include: atelectasis, nosocomial pneumonia, prolonged mechanical ventilation, respiratory failure, bronchospasm, pulmonary embolism.

Surgery

  • Surgery is the mainstay of treatment for large cell carcinoma of the lung.[1][2][3]
  • The feasibility of surgery depends on the stage of squamous cell carcinoma of the lung at diagnosis.
  • Surgical intervention is not recommended for the management of metastatic squamous cell carcinoma of the lung.

Surgical Options

  • Common surgical procedures for the treatment of large cell carcinoma of the lung, include: [4]

Indications

Surgery is usually reserved for patients with large cell carcinoma with the following characteristics:[5]

  • Pulmonary function testing:
  • Preoperative assessment of FEV1/DLCO
  • FEV1 >2 L (or more than 80%)
  • DLCO > 80
  • Exercise testing:
  • Successful cutoff of 22 m on the stair climbing test
  • Fitness for surgery:

Contraindications

Large cell carcinoma of the lung surgery is usually contraindicated in patients with the following characteristics: Large cell carcinoma of the lung extension past the diaphragm:

  • Extrathoracic metastases.
  • Metastases to supraclavicular lymph nodes.
  • Contralateral mediastinal node metastases.
  • Involvement of contralateral hemithorax.
  • Invasion to structures of the mediastinum.

Complications

Common complications of large cell carcinoma of the lung surgery, include:[2]

References

  1. Doddoli C, Barlesi F, Chetaille B, Garbe L, Thomas P, Giudicelli R, Fuentes P (April 2004). "Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery". Ann. Thorac. Surg. 77 (4): 1168–72. doi:10.1016/j.athoracsur.2003.09.049. PMID 15063228.
  2. 2.0 2.1 Smetana GW, Lawrence VA, Cornell JE (2006). "Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians". Ann. Intern. Med. 144 (8): 581–95. PMID 16618956.
  3. Wertzel H, Grahmann PR, Bansbach S, Lange W, Hasse J, Böhm N (November 1997). "Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression". Eur J Cardiothorac Surg. 12 (5): 698–702. PMID 9458138.
  4. Lung cancer surgery. Wikipedia. https://en.wikipedia.org/wiki/Lung_cancer_surgery Accessed on March 10, 2016
  5. von Groote-Bidlingmaier F, Koegelenberg CF, Bolliger CT (2011). "Functional evaluation before lung resection". Clin. Chest Med. 32 (4): 773–82. doi:10.1016/j.ccm.2011.08.001. PMID 22054885.


Template:WikiDoc Sources